Related references
Note: Only part of the references are listed.Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies
L. A. Marr et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients with Hematological Malignancies and Solid Tumors: Lessons from Early Clinical Trials
Ann Van Driessche et al.
ONCOLOGIST (2012)
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype
Aude G. Chapuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed
Jelena Popovic et al.
BLOOD (2011)
Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia
Martin Bornhaeuser et al.
BLOOD (2011)
An Interleukin-21-Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells
Weiguo Cui et al.
IMMUNITY (2011)
A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study
P. Chevallier et al.
LEUKEMIA (2011)
Establishment of Antitumor Memory in Humans Using in Vitro-Educated CD8+ T Cells
Marcus O. Butler et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Unfavorable-risk cytogenetics in acute myeloid leukemia
Wan-Jen Hong et al.
EXPERT REVIEW OF HEMATOLOGY (2011)
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes
Sara Galimberti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse
Saiko Kurosawa et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
WT1 (Wilms' Tumor Gene 1): Biology and Cancer Immunotherapy
Haruo Sugiyama
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia
Boglarka Gyurkocza et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
Daniela Cilloni et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Christian S. Hinrichs et al.
BLOOD (2008)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Ex Vivo Generation of Human Alloantigen-Specific Regulatory T Cells from CD4posCD25high T Cells for Immunotherapy
Jorieke H. Peters et al.
PLOS ONE (2008)
Cell permeabilization for the assessment of T lymphocyte polyfunctional capacity
Laura Papagno et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation
Marco Mielcarek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Richard A. Larson
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire
WY Ho et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response
YQ Li et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells
NL Alves et al.
JOURNAL OF IMMUNOLOGY (2005)
Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes
P Kebriaei et al.
BONE MARROW TRANSPLANTATION (2005)
Graft-versus-leukemia reactions in allogeneic chimeras
HJ Kolb et al.
BLOOD (2004)
CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients
AF Ochsenbein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Cancer immunotherapy: A treatment for the masses
JN Blattman et al.
SCIENCE (2004)
Restoration of CD28 expression in CD28-CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production
MS Topp et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines
J Geginat et al.
BLOOD (2003)
Lineage relationship and protective immunity of memory CD8 T cell subsets
EJ Wherry et al.
NATURE IMMUNOLOGY (2003)
Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia
AH Elmaagacli et al.
BLOOD (2003)
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
JJM van Dongen et al.
LEUKEMIA (2003)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells
C Yee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome
HJ Deeg et al.
BLOOD (2002)
Share Paper
